STOCK TITAN

Akebia Therapeutics to Present at H.C. Wainwright Global Investment Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Akebia Therapeutics, Inc. (Nasdaq: AKBA) will present at the H.C. Wainwright 25th Annual Global Investment Conference on September 11, 2023. The conference will be held in New York from September 11-13, 2023. The webcast of the presentation can be accessed through Akebia's website, with a replay available for approximately 90 days.
Positive
  • None.
Negative
  • None.

CAMBRIDGE, Mass., Sept. 6, 2023 /PRNewswire/ -- Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that John Butler, Chief Executive Officer, will present at the H.C. Wainwright 25th Annual Global Investment Conference on Monday, September 11, 2023 at 9:30 a.m. ET.

The H.C. Wainwright Global Investment Conference will take place September 11-13, 2023, in New York. 

A webcast of the presentation can be accessed through the Investors section of Akebia's website at https://ir.akebia.com. A replay of the webcast will also be available for approximately 90 days following the conference through the Investors section of Akebia's website at https://ir.akebia.com.

About Akebia Therapeutics
Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. Akebia was founded in 2007 and is headquartered in Cambridge, Massachusetts. For more information, please visit our website at www.akebia.com, which does not form a part of this release.

Akebia Therapeutics Contact
Mercedes Carrasco
Mcarrasco@akebia.com 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/akebia-therapeutics-to-present-at-hc-wainwright-global-investment-conference-301918518.html

SOURCE Akebia Therapeutics

FAQ

When will Akebia Therapeutics, Inc. present at the H.C. Wainwright 25th Annual Global Investment Conference?

Akebia Therapeutics, Inc. will present at the H.C. Wainwright 25th Annual Global Investment Conference on Monday, September 11, 2023 at 9:30 a.m. ET.

Where will the H.C. Wainwright Global Investment Conference take place?

The H.C. Wainwright Global Investment Conference will take place in New York from September 11-13, 2023.

How can the webcast of the presentation be accessed?

The webcast of the presentation can be accessed through the Investors section of Akebia's website at https://ir.akebia.com.

For how long will the replay of the webcast be available?

A replay of the webcast will be available for approximately 90 days following the conference through the Investors section of Akebia's website at https://ir.akebia.com.

Akebia Therapeutics, Inc.

NASDAQ:AKBA

AKBA Rankings

AKBA Latest News

AKBA Stock Data

287.15M
188.22M
2.47%
26.27%
6.4%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
United States of America
CAMBRIDGE

About AKBA

akebia therapeutics, inc. is a biopharmaceutical company headquartered in cambridge, massachusetts, focused on delivering innovative therapies to patients with kidney disease through hypoxia-inducible factor (hif) biology. akebia’s lead product candidate, vadadustat, is an investigational oral therapy in development for the treatment of anemia related to chronic kidney disease in both non-dialysis and dialysis patients. akebia’s global phase 3 program for vadadustat, which includes the pro2tect studies for non-dialysis patients with anemia associated with chronic kidney disease and the inno2vate studies for dialysis-dependent patients, is currently ongoing. for more information, please visit our website at www.akebia.com.